
Artificial intelligence-based software approved by FDA to assist in screening of prostate cancer
On September 21, 2021, the FDA approved marketing of software dedicated to assisting medical professionals, particularly pathologists, in the detection of suspicious areas in body tissue for cancer. This software is to be used as an adjunct to the review…